---
title: "Lunai Bioworks delays annual report, expects net loss of about $3.2 million"
url: "https://aibio.space/news/lunai-bioworks-delays-annual-report-expects-net-loss-about-3-2-million/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-09-29"
section: "Distress"
tickers: "NASDAQ:LNAI"
source: "https://www.sec.gov/Archives/edgar/data/1527728/000173112226001299/e7978_nt10-k.htm"
summary: "The company, formerly Renovaro Inc., expects to file its Form 10-K for the year ended June 30, 2026 within the 15-day grace period. Its net loss for the pr"
---

By the aibio.space news desk.

Sources

- [Lunai Bioworks Inc. NT 10-K (2026-09-29)](https://www.sec.gov/Archives/edgar/data/1527728/000173112226001299/e7978_nt10-k.htm)

[LNAI](https://aibio.space/companies/lunai-bioworks/)

2026-09-29

# Lunai Bioworks delays annual report, expects net loss of about $3.2 million

Tickers [LNAI](https://aibio.space/companies/lunai-bioworks/)

The company, formerly Renovaro Inc., expects to file its Form 10-K for the year ended June 30, 2026 within the 15-day grace period. Its net loss for the prior year was about $178.0 million.

## Key facts

- **Company**: Lunai Bioworks Inc. (NASDAQ: LNAI)

- **News type**: Distress

- **Primary source**: [Lunai Bioworks Inc. NT 10-K (2026-09-29)](https://www.sec.gov/Archives/edgar/data/1527728/000173112226001299/e7978_nt10-k.htm)

*The White House and its lawn. CC0, via rawpixel. The picture shows the field, not the companies named.*

Lunai Bioworks Inc. (Nasdaq: [LNAI](https://aibio.space/companies/lunai-bioworks/)), formerly Renovaro Inc., said it cannot file its annual report on Form 10-K for the fiscal year ended June 30, 2026 on time without unreasonable effort or expense.

In a [late filing notice dated September 29, 2026](https://www.sec.gov/Archives/edgar/data/1527728/000173112226001299/e7978_nt10-k.htm), the Sacramento, California company said it expects to file the report on or before the fifteenth calendar day after the due date, as Rule 12b-25(b) permits.

Lunai expects a net loss of approximately $3.2 million for the year, compared with approximately $178.0 million for the year ended June 30, 2025. It said the smaller loss mainly reflects the absence of the approximately $170.4 million goodwill impairment charge recorded in fiscal 2025. General and administrative expenses fell about $10.4 million after a restructuring. The company also recognized a gain of approximately $12.0 million on the deconsolidation of GEDi Cube B.V. following that unit's bankruptcy.

Those items were partly offset by an approximately $7.4 million loss on extinguishment of debt tied to the company's fiscal 2026 debt restructuring and debt exchange transactions. There was also an impairment of about $0.832 million on long-lived assets and a less favorable change of approximately $11.1 million in the fair value of contingent consideration.

The company said the figures are preliminary and unaudited.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

LNAI

Lunai Bioworks Inc.

NASDAQ · United States

Open the starter desk

## More in Distress

Distress

### [Mineralys takes ownership of lorundrostat patents but keeps Tanabe milestone debts](https://aibio.space/news/mineralys-takes-ownership-lorundrostat-patents-but-keeps-tanabe/)

Oct 29, 2026

Distress

### [Bristol Myers Squibb drops Prothena's PRX019, ending up to $617.5 million in milestones](https://aibio.space/news/bristol-myers-squibb-drops-prothenas-prx019-ending-up-617-5-million/)

Oct 29, 2026

Distress

### [LENZ Therapeutics reorganizes to cut 2027 operating expenses by more than 50%](https://aibio.space/news/lenz-therapeutics-reorganizes-cut-2027-operating-expenses-more-50/)

Oct 28, 2026

---
Source page: https://aibio.space/news/lunai-bioworks-delays-annual-report-expects-net-loss-about-3-2-million/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Lunai Bioworks delays annual report, expects net loss of about $3.2 million", 2026-09-29, https://aibio.space/news/lunai-bioworks-delays-annual-report-expects-net-loss-about-3-2-million/